Yumanity Therapeutics Inc

NASDAQ:YMTX   3:59:51 PM EDT
1.65
-0.03 (-1.79%)
Earnings Announcements

Yumanity Therapeutics Reports Second Quarter 2022 Financial Results And Recent Corporate Developments

Published: 08/04/2022 21:16 GMT
Yumanity Therapeutics Inc (YMTX) - Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments.
Qtrly Loss per Share $0.45.
Revenue is expected to be $2.5 Million
Adjusted EPS is expected to be -$0.99

Next Quarter Revenue Guidance is expected to be $2.5 Million
Next Quarter EPS Guidance is expected to be -$1.08

More details on our Analysts Page.